ATF4 and neurodegenerative disease: The increase in P-eIF2α and ATF4 has been observed in many neurodegenerative diseases (Oliveira and Lourenco, 2016; Zhu et al., 2019; Ghadge et al., 2020; Chang et al., 2022; Hu et al., 2022).